148 related articles for article (PubMed ID: 38431926)
1. Metal-Organic Framework Based Mucoadhesive Nanodrugs for Multifunction Helicobacter Pylori Targeted Eradication, Inflammation Regulation and Gut Flora Protection.
Zhou Y; Zhang W; He C; Shu C; Xu X; Wang H; Fei X; Li N; Hu Y; Xie C; Lu N; Wang X; Zhu Y
Small; 2024 Jun; 20(24):e2308286. PubMed ID: 38431926
[TBL] [Abstract][Full Text] [Related]
2. An all-in-one therapeutic platform for the treatment of resistant Helicobacter pylori infection.
Sun C; Huang J; Guo X; Zhang C; Wei L; Wong KI; Yang Z; Zhao G; Lu M; Yao W
Biomaterials; 2024 Jul; 308():122540. PubMed ID: 38537343
[TBL] [Abstract][Full Text] [Related]
3. Metal-Organic-Framework-Based Hydrogen-Release Platform for Multieffective Helicobacter Pylori Targeting Therapy and Intestinal Flora Protective Capabilities.
Zhang W; Zhou Y; Fan Y; Cao R; Xu Y; Weng Z; Ye J; He C; Zhu Y; Wang X
Adv Mater; 2022 Jan; 34(2):e2105738. PubMed ID: 34655499
[TBL] [Abstract][Full Text] [Related]
4. The eradication of Helicobacter pylori restores rather than disturbs the gastrointestinal microbiota in asymptomatic young adults.
He C; Peng C; Wang H; Ouyang Y; Zhu Z; Shu X; Zhu Y; Lu N
Helicobacter; 2019 Aug; 24(4):e12590. PubMed ID: 31124220
[TBL] [Abstract][Full Text] [Related]
5. Co-administration of amoxicillin-loaded chitosan nanoparticles and inulin: A novel strategy for mitigating antibiotic resistance and preserving microbiota balance in Helicobacter pylori treatment.
Fayed B; Jagal J; Cagliani R; Kedia RA; Elsherbeny A; Bayraktutan H; Khoder G; Haider M
Int J Biol Macromol; 2023 Dec; 253(Pt 2):126706. PubMed ID: 37673144
[TBL] [Abstract][Full Text] [Related]
6. Residence Time-Extended Nanoparticles by Magnetic Field Improve the Eradication Efficiency of
Yang SJ; Huang CH; Yang JC; Wang CH; Shieh MJ
ACS Appl Mater Interfaces; 2020 Dec; 12(49):54316-54327. PubMed ID: 33236884
[No Abstract] [Full Text] [Related]
7. Gastric Acid-Responsive ROS Nanogenerators for Effective Treatment of Helicobacter pylori Infection without Disrupting Homeostasis of Intestinal Flora.
Yu J; Guo Z; Yan J; Bu C; Peng C; Li C; Mao R; Zhang J; Wang Z; Chen S; Yao M; Xie Z; Yang C; Yang YY; Yuan P; Ding X
Adv Sci (Weinh); 2023 Jul; 10(20):e2206957. PubMed ID: 37127895
[TBL] [Abstract][Full Text] [Related]
8. Treatment of Helicobacter pylori infection and its long-term impacts on gut microbiota.
Liou JM; Lee YC; Wu MS
J Gastroenterol Hepatol; 2020 Jul; 35(7):1107-1116. PubMed ID: 31984532
[TBL] [Abstract][Full Text] [Related]
9. Gastrointestinal microbiome and
Sitkin S; Lazebnik L; Avalueva E; Kononova S; Vakhitov T
World J Gastroenterol; 2022 Feb; 28(7):766-774. PubMed ID: 35317277
[No Abstract] [Full Text] [Related]
10. Metal-Based Nanoparticles: A Prospective Strategy for
Yin X; Lai Y; Du Y; Zhang T; Gao J; Li Z
Int J Nanomedicine; 2023; 18():2413-2429. PubMed ID: 37192898
[No Abstract] [Full Text] [Related]
11. Helicobacter pylori eradication with bismuth quadruple therapy leads to dysbiosis of gut microbiota with an increased relative abundance of Proteobacteria and decreased relative abundances of Bacteroidetes and Actinobacteria.
Hsu PI; Pan CY; Kao JY; Tsay FW; Peng NJ; Kao SS; Wang HM; Tsai TJ; Wu DC; Chen CL; Tsai KW;
Helicobacter; 2018 Aug; 23(4):e12498. PubMed ID: 29897654
[TBL] [Abstract][Full Text] [Related]
12. Long-term changes of gut microbiota, antibiotic resistance, and metabolic parameters after Helicobacter pylori eradication: a multicentre, open-label, randomised trial.
Liou JM; Chen CC; Chang CM; Fang YJ; Bair MJ; Chen PY; Chang CY; Hsu YC; Chen MJ; Chen CC; Lee JY; Yang TH; Luo JC; Chen CY; Hsu WF; Chen YN; Wu JY; Lin JT; Lu TP; Chuang EY; El-Omar EM; Wu MS;
Lancet Infect Dis; 2019 Oct; 19(10):1109-1120. PubMed ID: 31559966
[TBL] [Abstract][Full Text] [Related]
13. Second-line levofloxacin-based quadruple therapy versus bismuth-based quadruple therapy for Helicobacter pylori eradication and long-term changes to the gut microbiota and antibiotic resistome: a multicentre, open-label, randomised controlled trial.
Liou JM; Jiang XT; Chen CC; Luo JC; Bair MJ; Chen PY; Chou CK; Fang YJ; Chen MJ; Chen CC; Lee JY; Yang TH; Yu CC; Kuo CC; Chiu MC; Chen CY; Shun CT; Hu WH; Tsai MH; Hsu YC; Tseng CH; Chang CY; Lin JT; El-Omar EM; Wu MS;
Lancet Gastroenterol Hepatol; 2023 Mar; 8(3):228-241. PubMed ID: 36549320
[TBL] [Abstract][Full Text] [Related]
14. The Effect of Probiotics on Gut Microbiota during the Helicobacter pylori Eradication: Randomized Controlled Trial.
Oh B; Kim BS; Kim JW; Kim JS; Koh SJ; Kim BG; Lee KL; Chun J
Helicobacter; 2016 Jun; 21(3):165-74. PubMed ID: 26395781
[TBL] [Abstract][Full Text] [Related]
15. Gut microbiota changes related to Helicobacter pylori eradication with vonoprazan containing triple therapy among adolescents: a prospective multicenter study.
Kakiuchi T; Yamamoto K; Imamura I; Hashiguchi K; Kawakubo H; Yamaguchi D; Fujioka Y; Okuda M
Sci Rep; 2021 Jan; 11(1):755. PubMed ID: 33436953
[TBL] [Abstract][Full Text] [Related]
16. Anti-Helicobacterpylori effectiveness and targeted delivery performance of amoxicillin-UCCs-2/TPP nanoparticles based on ureido-modified chitosan derivative.
Jing ZW; Luo M; Jia YY; Li C; Zhou SY; Mei QB; Zhang BL
Int J Biol Macromol; 2018 Aug; 115():367-374. PubMed ID: 29660462
[TBL] [Abstract][Full Text] [Related]
17. A nanoparticle-based sonodynamic therapy reduces Helicobacter pylori infection in mouse without disrupting gut microbiota.
Liu T; Chai S; Li M; Chen X; Xie Y; Zhao Z; Xie J; Yu Y; Gao F; Zhu F; Yang L
Nat Commun; 2024 Jan; 15(1):844. PubMed ID: 38286999
[TBL] [Abstract][Full Text] [Related]
18. In vivo treatment of Helicobacter pylori infection with liposomal linolenic acid reduces colonization and ameliorates inflammation.
Thamphiwatana S; Gao W; Obonyo M; Zhang L
Proc Natl Acad Sci U S A; 2014 Dec; 111(49):17600-5. PubMed ID: 25422427
[TBL] [Abstract][Full Text] [Related]
19. Helicobacter pylori and oral-gut microbiome: clinical implications.
Elghannam MT; Hassanien MH; Ameen YA; Turky EA; ELattar GM; ELRay AA; ELTalkawy MD
Infection; 2024 Apr; 52(2):289-300. PubMed ID: 37917397
[TBL] [Abstract][Full Text] [Related]
20. A pH-Responsive Persistent Luminescence Nanozyme for Selective Imaging and Killing of
Yan LX; Wang BB; Zhao X; Chen LJ; Yan XP
ACS Appl Mater Interfaces; 2021 Dec; 13(51):60955-60965. PubMed ID: 34904434
[No Abstract] [Full Text] [Related]
[Next] [New Search]
